{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:09:36Z","timestamp":1772806176488,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol. Sin."],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s12250-014-3516-9","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T13:18:22Z","timestamp":1414675102000},"page":"265-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Varicella zoster virus vaccines: potential complications and possible improvements"],"prefix":"10.1016","volume":"29","author":[{"given":"Benjamin","family":"Silver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2014,10,24]]},"reference":[{"key":"3516_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-065X.1999.tb01289.x","volume":"168","author":"A Abendroth","year":"1999","unstructured":"Abendroth A, Arvin A. 1999. Varicella-zoster virus immune evasion. Immunological reviews, 168: 143\u2013156.","journal-title":"Immunological reviews"},{"key":"3516_CR2","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1212\/WNL.45.12_Suppl_8.S36","volume":"45","author":"A M Arvin","year":"1995","unstructured":"Arvin A M. 1995. Aspects of the host response to varicella-zoster virus: a review of recent observations. Neurology, 45: S36\u201337.","journal-title":"Neurology"},{"key":"3516_CR3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1369-5274(00)00233-2","volume":"4","author":"A M Arvin","year":"2001","unstructured":"Arvin A M. 2001. Varicella-zoster virus: molecular virology and virus-host interactions. Curr Opin Microbiol, 4: 442\u2013449.","journal-title":"Curr Opin Microbiol"},{"key":"3516_CR4","first-page":"114","volume":"90","author":"G Chesnut","year":"2012","unstructured":"Chesnut G, McClain D, Galeckas K. 2012. Varicella-zoster virus in children immunized with the varicella vaccine. Cutis, 90: 114\u2013116.","journal-title":"Cutis"},{"key":"3516_CR5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/infdis\/172.3.706","volume":"172","author":"P W Choo","year":"1995","unstructured":"Choo P W, Donahue J G, Manson J E, Platt R. 1995. The epide-miology of varicella and its complications. J Infect Dis, 172: 706\u2013712.","journal-title":"J Infect Dis"},{"key":"3516_CR6","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1073\/pnas.90.15.7376","volume":"90","author":"J I Cohen","year":"1993","unstructured":"Cohen J I, Seidel K E. 1993. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci U S A, 90: 7376\u20137380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3516_CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/rmv.377","volume":"13","author":"N L Cole","year":"2003","unstructured":"Cole N L, Grose C. 2003. Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus. Rev Med Virol, 13: 207\u2013222.","journal-title":"Rev Med Virol"},{"key":"3516_CR8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11307-005-0019-y","volume":"7","author":"A M Collaco","year":"2005","unstructured":"Collaco A M, Rahman S, Dougherty E J, Williams B B, Geusz M E. 2005. Circadian regulation of a viral gene promoter in live transgenic mice expressing firefly luciferase. Mol Imaging Biol, 7: 342\u2013350.","journal-title":"Mol Imaging Biol"},{"key":"3516_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.bioeng.4.111901.093336","volume":"4","author":"C H Contag","year":"2002","unstructured":"Contag C H, Bachmann M H. 2002. Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng, 4: 235\u2013260.","journal-title":"Annu Rev Biomed Eng"},{"key":"3516_CR10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1751-1097.1997.tb03184.x","volume":"66","author":"C H Contag","year":"1997","unstructured":"Contag C H, Spilman S D, Contag P R, Oshiro M, Eames B, Dennery P, Stevenson D K, Benaron D A. 1997. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol, 66: 523\u2013531.","journal-title":"Photochem Photobiol"},{"key":"3516_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1462-5822.2004.00378.x","volume":"6","author":"T C Doyle","year":"2004","unstructured":"Doyle T C, Burns S M, Contag C H. 2004. In vivo bioluminescence imaging for integrated studies of infection. Cell Microbiol, 6: 303\u2013317.","journal-title":"Cell Microbiol"},{"key":"3516_CR12","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1503\/cmaj.091711","volume":"182","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Schmader K E, Levin M J, Johnson R, Oxman M N, Patrick D, Blanchette C, Mansi J A. 2010. The impact of herpes zoster and postherpetic neuralgia on healthrelated quality of life: a prospective study. CMAJ: Canadian Medical Association journal = journal de l\u2019Association medicale canadienne, 182: 1731\u20131736.","journal-title":"CMAJ: Canadian Medical Association journal = journal de l\u2019Association medicale canadienne"},{"key":"3516_CR13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jviromet.2008.12.021","volume":"157","author":"K Dulal","year":"2009","unstructured":"Dulal K, Zhang Z, Zhu H. 2009. Development of a gene capture method to rescue a large deletion mutant of human cytomegalovirus. Journal of Virological Methods, 157: 180\u2013187.","journal-title":"Journal of Virological Methods"},{"key":"3516_CR14","volume-title":"Biomed and Biotechnol","author":"K Dulal","year":"2012","unstructured":"Dulal K, Silver B, Zhu H. 2012. Use of Recombination-Mediated Genetic Engineering for Construction of Rescue Human Cytomegalovirus Bacterial Artificial Chromosome Clones. Biomed and Biotechnol."},{"key":"3516_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jviromet.2004.11.023","volume":"125","author":"S Fan","year":"2005","unstructured":"Fan S, Maguire C A, Ramirez S H, Bradel-Tretheway B, Sapinoro R, Sui Z, Chakraborty-Sett S, Dewhurst S. 2005. Valproic acid enhances gene expression from viral gene transfer vectors. J Virol Methods, 125: 23\u201333.","journal-title":"J Virol Methods"},{"key":"3516_CR16","first-page":"173","volume":"342","author":"M D Gershon","year":"2010","unstructured":"Gershon M D, Gershon A A. 2010. VZV infection of keratinocytes: production of cell-free infectious virions in vivo. Curr Top Microbiol Immunol, 342: 173\u2013188.","journal-title":"Curr Top Microbiol Immunol"},{"key":"3516_CR17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM200003023420906","volume":"342","author":"D H Gilden","year":"2000","unstructured":"Gilden D H, Kleinschmidt-DeMasters B K, LaGuardia J J, Mahalingam R, Cohrs R J. 2000. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med, 342: 635\u2013645.","journal-title":"N Engl J Med"},{"key":"3516_CR18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1532-5415.1984.tb06298.x","volume":"32","author":"J P Harnisch","year":"1984","unstructured":"Harnisch J P. 1984. Zoster in the elderly: clinical, immunologic and therapeutic considerations. J Am Geriatr Soc, 32: 789\u2013793.","journal-title":"J Am Geriatr Soc"},{"key":"3516_CR19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02101634","volume":"19","author":"J W Hastings","year":"1983","unstructured":"Hastings J W. 1983. Biological diversity, chemical mechanisms, and the evolutionary origins of bioluminescent systems. J Mol Evol, 19: 309\u2013321.","journal-title":"J Mol Evol"},{"key":"3516_CR20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/INF.0b013e3181598315","volume":"27","author":"T Hatchette","year":"2008","unstructured":"Hatchette T, Tipples G A, Peters G, Alsuwaidi A, Zhou J, Mailman T L. 2008. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature. Pediatr Infect Dis J, 27: 75\u201377.","journal-title":"Pediatr Infect Dis J"},{"key":"3516_CR21","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","volume":"356","author":"D W Kimberlin","year":"2007","unstructured":"Kimberlin D W, Whitley R J. 2007. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med, 356: 1338\u20131343.","journal-title":"N Engl J Med"},{"key":"3516_CR22","volume-title":"Cochrane Database Syst Rev: CD002980","author":"T P Klassen","year":"2005","unstructured":"Klassen T P, Hartling L, Wiebe N, Belseck E M. 2005. Acyclovir for treating varicella in otherwise healthy children and adolescents. Cochrane Database Syst Rev: CD002980."},{"key":"3516_CR23","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1021\/bi00276a001","volume":"22","author":"M Kurfurst","year":"1983","unstructured":"Kurfurst M, Ghisla S, Hastings J W. 1983. Bioluminescence emission from the reaction of luciferase-flavin mononucleotide radical with O2. Biochemistry, 22: 1521\u20131525.","journal-title":"Biochemistry"},{"key":"3516_CR24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","volume":"52","author":"J Leung","year":"2011","unstructured":"Leung J, Harpaz R, Molinari N A, Jumaan A, Zhou F. 2011. Herpes zoster incidence among insured persons in the United States, 1993\u20132006: evaluation of impact of varicella vaccination. Clin Infect Dis, 52: 332\u2013340.","journal-title":"Clin Infect Dis"},{"key":"3516_CR25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.icu.0000143686.68103.46","volume":"15","author":"T J Liesegang","year":"2004","unstructured":"Liesegang T J. 2004. Herpes zoster virus infection. Curr Opin Ophthalmol, 15: 531\u2013536.","journal-title":"Curr Opin Ophthalmol"},{"key":"3516_CR26","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1212\/WNL.45.12_Suppl_8.S52","volume":"45","author":"E Lydick","year":"1995","unstructured":"Lydick E, Epstein R S, Himmelberger D, White C J. 1995. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology, 45: S52\u201353.","journal-title":"Neurology"},{"key":"3516_CR27","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1016\/j.vaccine.2004.03.062","volume":"22","author":"K Nagaike","year":"2004","unstructured":"Nagaike K, Mori Y, Gomi Y, Yoshii H, Takahashi M, Wagner M, Koszinowski U, Yamanishi K. 2004. Cloning of the varicellazoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine, 22: 4069\u20134074.","journal-title":"Vaccine"},{"key":"3516_CR28","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1128\/JVI.77.10.6062-6065.2003","volume":"77","author":"T Niizuma","year":"2003","unstructured":"Niizuma T, Zerboni L, Sommer M H, Ito H, Hinchliffe S, Arvin A M. 2003. Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. J Virol, 77: 6062\u20136065.","journal-title":"J Virol"},{"key":"3516_CR29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/fampra\/19.5.471","volume":"19","author":"W Opstelten","year":"2002","unstructured":"Opstelten W, Mauritz J W, de Wit N J, van Wijck A J, Stalman W A, van Essen G A. 2002. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract, 19: 471\u2013475.","journal-title":"Fam Pract"},{"key":"3516_CR30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.neo.7900121","volume":"2","author":"A Rehemtulla","year":"2000","unstructured":"Rehemtulla A, Stegman L D, Cardozo S J, Gupta S, Hall D E, Contag C H, Ross B D. 2000. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia, 2: 491\u2013495.","journal-title":"Neoplasia"},{"key":"3516_CR31","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1128\/JVI.02592-07","volume":"82","author":"M Reichelt","year":"2008","unstructured":"Reichelt M, Zerboni L, Arvin A M. 2008. Mechanisms of varicellazoster virus neuropathogenesis in human dorsal root ganglia. J Virol, 82: 3971\u20133983.","journal-title":"J Virol"},{"key":"3516_CR32","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1128\/JVI.80.7.3592-3606.2006","volume":"80","author":"M M Saksena","year":"2006","unstructured":"Saksena M M, Wakisaka H, Tijono B, Boadle R A, Rixon F, Takahashi H, Cunningham A L. 2006. Herpes simplex virus type 1 accumulation, envelopment, and exit in growth cones and varicosities in mid-distal regions of axons. J Virol, 80: 3592\u20133606.","journal-title":"J Virol"},{"key":"3516_CR33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00431-002-0981-1","volume":"161","author":"B Uebe","year":"2002","unstructured":"Uebe B, Sauerbrei A, Burdach S, Horneff G. 2002. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child. Eur J Pediatr, 161: 442\u2013444.","journal-title":"Eur J Pediatr"},{"key":"3516_CR34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00008480-200402000-00015","volume":"16","author":"M Vazquez","year":"2004","unstructured":"Vazquez M. 2004. Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine. Curr Opin Pediatr, 16: 80\u201384.","journal-title":"Curr Opin Pediatr"},{"key":"3516_CR35","doi-asserted-by":"crossref","first-page":"124595","DOI":"10.1155\/2011\/124595","volume":"2011","author":"C Warden","year":"2011","unstructured":"Warden C, Tang Q, Zhu H. 2011. Herpesvirus BACs: past, present, and future. J Biomed Biotechnol, 2011: 124595.","journal-title":"J Biomed Biotechnol"},{"key":"3516_CR36","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/gni035","volume":"33","author":"S Warming","year":"2005","unstructured":"Warming S, Costantino N, Court D L, Jenkins N A, Copeland N G. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res, 33: e36.","journal-title":"Nucleic Acids Res"},{"issue":"Pt2","key":"3516_CR37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1242\/jcs.108.2.441","volume":"108","author":"M R White","year":"1995","unstructured":"White M R, Masuko M, Amet L, Elliott G, Braddock M, Kingsman A J, Kingsman S M. 1995. Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells. J Cell Sci, 108( Pt 2): 441\u2013455.","journal-title":"J Cell Sci"},{"key":"3516_CR38","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1086\/430328","volume":"191","author":"R J Whitley","year":"2005","unstructured":"Whitley R J. 2005. Changing dynamics of varicella-zoster virus infections in the 21st century: the impact of vaccination. J Infect Dis, 191: 1999\u20132001.","journal-title":"J Infect Dis"},{"key":"3516_CR39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2458-5-68","volume":"5","author":"W K Yih","year":"2005","unstructured":"Yih W K, Brooks D R, Lett S M, Jumaan A O, Zhang Z, Clements K M, Seward J F. 2005. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998\u20132003. BMC Public Health, 5: 68.","journal-title":"BMC Public Health"},{"key":"3516_CR40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s13365-011-0066-x","volume":"17","author":"L Zerboni","year":"2011","unstructured":"Zerboni L, Arvin A. 2011. Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts. J Neurovirol, 17: 570\u2013577.","journal-title":"J Neurovirol"},{"key":"3516_CR41","first-page":"255","volume":"342","author":"L Zerboni","year":"2010","unstructured":"Zerboni L, Reichelt M, Arvin A. 2010. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts. Curr Top Microbiol Immunol, 342: 255\u2013276.","journal-title":"Curr Top Microbiol Immunol"},{"key":"3516_CR42","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/78475","volume":"18","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Muyrers J P, Testa G, Stewart A F. 2000. DNA cloning by homologous recombination in Escherichia coli. Nat Biotechnol, 18: 1314\u20131317.","journal-title":"Nat Biotechnol"},{"key":"3516_CR43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jviromet.2007.11.012","volume":"148","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Huang Y, Zhu H. 2008. A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system. J Virol Methods, 148: 197\u2013204.","journal-title":"J Virol Methods"},{"key":"3516_CR44","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1128\/JVI.02666-06","volume":"81","author":"Z Zhang","year":"2007","unstructured":"Zhang Z, Rowe J, Wang W, Sommer M, Arvin A, Moffat J, Zhu H. 2007. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol, 81: 9024\u20139033.","journal-title":"J Virol"},{"key":"3516_CR45","doi-asserted-by":"crossref","first-page":"e1000971","DOI":"10.1371\/journal.ppat.1000971","volume":"6","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Selariu A, Warden C, Huang G, Huang Y, Zaccheus O, Cheng T, Xia N, Zhu H. 2010. Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor. PLoS pathogens, 6: e1000971.","journal-title":"PLoS pathogens"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-014-3516-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12250-014-3516-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-014-3516-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T23:02:18Z","timestamp":1650495738000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12250-014-3516-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["3516"],"URL":"https:\/\/doi.org\/10.1007\/s12250-014-3516-9","relation":{},"ISSN":["1674-0769","1995-820X"],"issn-type":[{"value":"1674-0769","type":"print"},{"value":"1995-820X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}